News
An autopsy confirms the cause of Hackman's death was heart disease. He was in the advanced stages of Alzheimer’s and may have ...
Alzheimer’s early detection is now more accessible with blood tests, as survey data shows nearly 80% of Americans want to ...
FOX 9 Minneapolis-St. Paul on MSN54m
New Alzheimer's drugs designed to slow diseaseDr. Ron Petersen at Mayo Clinic shares with FOX 9 about what they're seeing in patients with the new Alzheimer's drugs ...
Most Americans want to be proactive when faced with a diagnosis of Alzheimer’s disease, wishing to know as soon as possible and asking for simple, rapid and accurate testing, according to recent ...
The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...
Ever heard of Fischer's disease? No? Maybe that is not surprising, because it doesn't exist. But it could have. In fact, the ...
Alzheimer’s disease is the most common type of dementia and is considered a progressive disease with symptoms worsening with time. It causes damage to the brain’s neurons, which can lead to decreased ...
A harmful form of the tau protein, which builds up in Alzheimer's disease and similar brain disorders, can directly damage ...
The latest report from the nonprofit shows more than 7 million Americans are now living with Alzheimer's. There's also an increase in people dying from the disease.
A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...
SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow memory loss, giving patients the gift of more time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results